Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biodesix, Inc. - Common Stock (NQ:BDSX)

0.4230 +0.0388 (+10.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
Topics Product Recall
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Before 10 a.m. ET on Wednesday, 49 companies set new 52-week lows. Noteworthy Highlights: The largest company in terms of market cap to set a new 52-week low was China... 
Via Benzinga
Looking Into Biodesix's Return On Capital Employed
During Q1, Biodesix's (NASDAQ:BDSX) reported sales totaled $28.87 million. Despite a 110.44% in earnings, the company posted a loss of $5.58 million. In Q4, Biodesix brought in $... 
Via Benzinga
Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer
From Biodesix, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning, 51 companies reached new 52-week lows. Noteworthy Highlights: China Life Insurance Co (NYSE:LFC) was the largest company by market cap to set a new... 
Via Benzinga
Biodesix Announces Commercial Availability of SARS CoV-2 Neutralization Antibody Test
From Biodesix, Inc.
Via Business Wire
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
Biodesix Partners with Datavant to Enhance Value of Lung Cancer Databank
From Biodesix
Via Business Wire
Biodesix: Return On Capital Employed Insights
During Q1, Biodesix's (NASDAQ:BDSX) reported sales totaled $28.87 million. Despite a 110.44% in earnings, the company posted a loss of $5.58 million. Biodesix collected $27.03... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 20.74% to $4.54 during Wednesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
Biodesix to Present at the William Blair 41st Annual Growth Stock Conference
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Sio Gene Therapies (NASDAQ:SIOX) ... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday morning, 15 companies hit new 52-week lows. Noteworthy Highlights: Canadian Pacific Railway (NYSE:CP) was the largest firm by market cap to set a new 52-... 
Via Benzinga
Biodesix, Inc. (BDSX) Q1 2021 Earnings Call Transcript
BDSX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Biodesix Announces First Quarter 2021 Results
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Intent to Launch Liquid Biopsy Next Generation Sequencing Test with Unprecedented Turnaround Time
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Presentation on SARS-CoV-2 Neutralizing Antibody Testing for Individual Vaccine Response and Commercial Launch Plans
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of... 
Via Benzinga
Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Presentation on Use of Biomarker-Based Risk Assessment to Inform Lung Nodule Management
From Biodesix, Inc.
Via Business Wire
Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Patients
From Biodesix, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.